NO975729L - Forbindelser og peptider som binder til etytropoietinreseptoren - Google Patents
Forbindelser og peptider som binder til etytropoietinreseptorenInfo
- Publication number
- NO975729L NO975729L NO975729A NO975729A NO975729L NO 975729 L NO975729 L NO 975729L NO 975729 A NO975729 A NO 975729A NO 975729 A NO975729 A NO 975729A NO 975729 L NO975729 L NO 975729L
- Authority
- NO
- Norway
- Prior art keywords
- hoc
- amino
- receptor
- ethytropoietin
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/484,631 US5830851A (en) | 1993-11-19 | 1995-06-07 | Methods of administering peptides that bind to the erythropoietin receptor |
US08/484,635 US5773569A (en) | 1993-11-19 | 1995-06-07 | Compounds and peptides that bind to the erythropoietin receptor |
PCT/US1996/009810 WO1996040749A1 (en) | 1995-06-07 | 1996-06-07 | Compounds and peptides that bind to the erythropoietin receptor |
Publications (3)
Publication Number | Publication Date |
---|---|
NO975729D0 NO975729D0 (no) | 1997-12-05 |
NO975729L true NO975729L (no) | 1998-02-05 |
NO318783B1 NO318783B1 (no) | 2005-05-09 |
Family
ID=27048076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19975729A NO318783B1 (no) | 1995-06-07 | 1997-12-05 | Peptid som binder til erytropoietinreseptoren og anvendelse derav, samt farmasoytiske blandinger som inneholder peptidet. |
Country Status (18)
Country | Link |
---|---|
EP (2) | EP0886648B8 (no) |
JP (3) | JP4050314B2 (no) |
KR (1) | KR100459984B1 (no) |
CN (1) | CN1192748A (no) |
AT (1) | ATE254138T1 (no) |
AU (1) | AU712713B2 (no) |
BR (1) | BR9609006A (no) |
CA (1) | CA2223833C (no) |
CZ (1) | CZ391097A3 (no) |
DE (1) | DE69630708T2 (no) |
ES (1) | ES2210374T3 (no) |
HU (1) | HUP9901069A2 (no) |
IL (1) | IL122417A0 (no) |
NO (1) | NO318783B1 (no) |
NZ (1) | NZ310804A (no) |
PL (1) | PL185040B1 (no) |
TR (1) | TR199701557T2 (no) |
WO (1) | WO1996040749A1 (no) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5830851A (en) * | 1993-11-19 | 1998-11-03 | Affymax Technologies N.V. | Methods of administering peptides that bind to the erythropoietin receptor |
US5773569A (en) * | 1993-11-19 | 1998-06-30 | Affymax Technologies N.V. | Compounds and peptides that bind to the erythropoietin receptor |
US5767078A (en) * | 1995-06-07 | 1998-06-16 | Johnson; Dana L. | Agonist peptide dimers |
US6121416A (en) * | 1997-04-04 | 2000-09-19 | Genentech, Inc. | Insulin-like growth factor agonist molecules |
DE19904406A1 (de) * | 1999-02-04 | 2000-08-10 | Bayer Ag | Substituierte Pyrazolcarbonsäuren |
DE19904396A1 (de) * | 1999-02-04 | 2000-08-10 | Bayer Ag | Substituierte Pyrazolbenzylamin-Derivate |
US6703480B1 (en) | 1999-11-24 | 2004-03-09 | Palani Balu | Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use |
US7259146B2 (en) | 2000-05-26 | 2007-08-21 | Ortho-Mcneil Pharmaceutical, Inc. | Neuroprotective peptides |
GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
JP4975966B2 (ja) | 2002-12-31 | 2012-07-11 | ネクター セラピューティクス | ケトンまたは関連する官能基を含むポリマー試薬 |
EP1628686A2 (en) | 2003-05-12 | 2006-03-01 | Affymax, Inc. | Spacer moiety for poly (ethylene glycol)-modified peptides |
KR20060028675A (ko) | 2003-05-12 | 2006-03-31 | 아피맥스, 인크. | 신규한 폴리 (에틸렌 글리콜) 개질 화합물 및 그의 용도 |
NZ543935A (en) | 2003-05-12 | 2008-06-30 | Affymax Inc | Peptides that bind to the erythropoietin receptor |
OA13164A (en) | 2003-05-12 | 2006-12-13 | Affymax Inc | Novel peptides that bind to the erythropoietin receptor. |
WO2005000360A2 (en) | 2003-05-23 | 2005-01-06 | Nektar Therapeutics Al, Corporation | Peg derivatives having an amidocarbonate linkage |
PL1675622T3 (pl) | 2003-09-17 | 2017-11-30 | Nektar Therapeutics | Proleki na bazie wieloramiennego polimeru |
CA2758460C (en) | 2003-12-16 | 2014-09-23 | Nektar Therapeutics | Methods of preparing monodisperse oligo (ethylene glycol) reagent compositions |
JP2007529475A (ja) * | 2004-03-17 | 2007-10-25 | アプラーゲン ゲゼルシャフト ミット ベシュレンクテル ハフツング | 等比体積の形態変換 |
WO2005107815A2 (en) | 2004-05-03 | 2005-11-17 | Nektar Therapeutics Al, Corporation | Polymer derivatives comprising an imide branching point |
US8562965B2 (en) | 2004-05-03 | 2013-10-22 | Nektar Therapeutics | Polymer derivatives comprising an acetal or ketal branching point |
US7589063B2 (en) | 2004-12-14 | 2009-09-15 | Aplagen Gmbh | Molecules which promote hematopoiesis |
JP2008519589A (ja) * | 2004-11-10 | 2008-06-12 | アプラゲン ゲーエムベーハー | 造血を促進する分子 |
KR20070108140A (ko) * | 2004-11-11 | 2007-11-08 | 아피맥스, 인크. | 에리트로포이에틴 수용체에 결합하는 신규한 펩타이드 |
JPWO2006115274A1 (ja) * | 2005-04-26 | 2008-12-18 | 味の素株式会社 | 骨髄赤血球前駆細胞分化促進剤 |
US7550433B2 (en) | 2005-06-03 | 2009-06-23 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
US20100145006A1 (en) * | 2005-06-23 | 2010-06-10 | Hans-Georg Frank | Supravalent compounds |
EA015672B1 (ru) * | 2005-08-05 | 2011-10-31 | Араим Фармасьютикалз, Инк. | Тканезащитные пептиды и их применения |
MX2008011389A (es) * | 2006-03-09 | 2009-01-26 | Aplagen Gmbh | Moleculas modificadas las cuales promueven hematopoyesis. |
CN101528263B (zh) | 2006-06-30 | 2013-01-23 | Sku资产管理有限公司 | 用于癌症的先天性免疫方法的缀合物 |
JP2010520855A (ja) | 2007-01-31 | 2010-06-17 | アフィーマックス・インコーポレイテッド | 修飾基をポリペプチドおよびその他の高分子に結合するための窒素ベースのリンカー |
EP2018835B1 (de) | 2007-07-09 | 2014-03-05 | Augustinus Bader | Wirkstoff abgebendes Pflaster |
CN101456911A (zh) * | 2007-12-12 | 2009-06-17 | 江苏豪森药业股份有限公司 | 促红细胞生成素模拟肽衍生物及其可药用盐和其制备方法与用途 |
CA2719940A1 (en) * | 2008-03-26 | 2009-11-26 | Orthologic Corp. | Methods for treating acute myocardial infarction |
WO2010014258A2 (en) | 2008-08-01 | 2010-02-04 | Nektar Therapeutics Al, Corporation | Conjugates having a releasable linkage |
MX2011001583A (es) | 2008-08-11 | 2011-04-04 | Nektar Therapeutics | Conjugados de alcanoato polimericos de multiples brazos. |
JP5766118B2 (ja) | 2008-09-11 | 2015-08-19 | ウェルズ ファーゴ バンク ナショナル アソシエイション | ポリマー性アルファ−ヒドロキシアルデヒドおよびケトン反応剤ならびに抱合方法 |
EP2350118B1 (en) | 2008-09-19 | 2016-03-30 | Nektar Therapeutics | Carbohydrate-based drug delivery polymers and conjugates thereof |
JP5694171B2 (ja) * | 2008-09-26 | 2015-04-01 | アンブルックス, インコーポレイテッドAmbrx, Inc. | 修飾されている動物のエリスロポエチンポリペプチドおよびそれらの使用 |
US20120190574A1 (en) * | 2009-06-19 | 2012-07-26 | The Arizona Board of Regents, A body Corporate of the State of Arizona for and on behalf of Arizona | Compound Arrays for Sample Profiling |
WO2011012306A2 (en) | 2009-07-30 | 2011-02-03 | Aplagen Gmbh | Use of emps for antagonising epo-stimulatory effects on epo-responsive tumors while maintaining erythropoiesis |
DK2590666T3 (en) | 2010-07-06 | 2017-07-17 | Augustinus Bader | TOPICAL APPLICATION OF ERYTHROPOIETIN FOR USE IN THE TREATMENT OF DAMAGE OF THE CORNS |
US10894087B2 (en) | 2010-12-22 | 2021-01-19 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds |
WO2012088422A1 (en) | 2010-12-22 | 2012-06-28 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of taxane-based compounds |
US20140088021A1 (en) | 2011-05-27 | 2014-03-27 | Nektar Therapeutics | Water-Soluble Polymer-Linked Binding Moiety and Drug Compounds |
WO2013171810A1 (ja) | 2012-05-14 | 2013-11-21 | パナソニック株式会社 | 耐熱性抗体提示ファージを得る方法 |
CN103450348B (zh) * | 2012-05-29 | 2016-03-30 | 中国人民解放军军事医学科学院毒物药物研究所 | 一种促红细胞生成素模拟肽、其制备方法和用途 |
CN106608906A (zh) * | 2015-10-22 | 2017-05-03 | 天津药物研究院有限公司 | 一种具有刺激红细胞生成功能的环形多肽的制备及其应用 |
CN106928338A (zh) * | 2015-12-31 | 2017-07-07 | 杭州阿德莱诺泰制药技术有限公司 | 促红细胞生成素肽及衍生物和聚合物、制备方法和应用 |
GB201609083D0 (en) | 2016-05-24 | 2016-07-06 | Syntab Therapeutics Gmbh | Synthetic compound |
CN113166203A (zh) * | 2018-09-14 | 2021-07-23 | Epo医药株式会社 | 抗促红细胞生成素受体肽 |
CA3142758A1 (en) | 2019-06-10 | 2020-12-17 | Respira Therapeutics,Inc. | Carrier-based formulations and related methods |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ210501A (en) * | 1983-12-13 | 1991-08-27 | Kirin Amgen Inc | Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence |
WO1990008822A1 (en) * | 1989-02-03 | 1990-08-09 | Genetics Institute, Inc. | Erythropoietin receptor |
DE3924746A1 (de) * | 1989-07-26 | 1991-01-31 | Behringwerke Ag | Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper |
US5767078A (en) * | 1995-06-07 | 1998-06-16 | Johnson; Dana L. | Agonist peptide dimers |
-
1996
- 1996-06-07 NZ NZ310804A patent/NZ310804A/xx not_active IP Right Cessation
- 1996-06-07 DE DE69630708T patent/DE69630708T2/de not_active Expired - Lifetime
- 1996-06-07 ES ES96919296T patent/ES2210374T3/es not_active Expired - Lifetime
- 1996-06-07 CA CA2223833A patent/CA2223833C/en not_active Expired - Fee Related
- 1996-06-07 AU AU61667/96A patent/AU712713B2/en not_active Ceased
- 1996-06-07 HU HU9901069A patent/HUP9901069A2/hu unknown
- 1996-06-07 JP JP50202397A patent/JP4050314B2/ja not_active Expired - Fee Related
- 1996-06-07 PL PL96323858A patent/PL185040B1/pl not_active IP Right Cessation
- 1996-06-07 IL IL12241796A patent/IL122417A0/xx unknown
- 1996-06-07 TR TR97/01557T patent/TR199701557T2/xx unknown
- 1996-06-07 KR KR1019970709231A patent/KR100459984B1/ko not_active IP Right Cessation
- 1996-06-07 AT AT96919296T patent/ATE254138T1/de not_active IP Right Cessation
- 1996-06-07 EP EP96919296A patent/EP0886648B8/en not_active Expired - Lifetime
- 1996-06-07 WO PCT/US1996/009810 patent/WO1996040749A1/en active IP Right Grant
- 1996-06-07 CN CN96196094A patent/CN1192748A/zh active Pending
- 1996-06-07 CZ CZ973910A patent/CZ391097A3/cs unknown
- 1996-06-07 EP EP03025811A patent/EP1510524A3/en not_active Withdrawn
- 1996-06-07 BR BR9609006-5A patent/BR9609006A/pt unknown
-
1997
- 1997-12-05 NO NO19975729A patent/NO318783B1/no not_active IP Right Cessation
-
2007
- 2007-07-18 JP JP2007186814A patent/JP2007277264A/ja active Pending
-
2009
- 2009-08-31 JP JP2009200615A patent/JP2009280616A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1510524A2 (en) | 2005-03-02 |
PL185040B1 (pl) | 2003-02-28 |
AU712713B2 (en) | 1999-11-11 |
JP2007277264A (ja) | 2007-10-25 |
JP2009280616A (ja) | 2009-12-03 |
CA2223833A1 (en) | 1996-12-19 |
KR100459984B1 (ko) | 2005-06-20 |
DE69630708T2 (de) | 2004-08-05 |
ATE254138T1 (de) | 2003-11-15 |
EP0886648B1 (en) | 2003-11-12 |
JPH11507367A (ja) | 1999-06-29 |
NO975729D0 (no) | 1997-12-05 |
EP0886648A4 (en) | 2000-01-12 |
WO1996040749A1 (en) | 1996-12-19 |
NO318783B1 (no) | 2005-05-09 |
BR9609006A (pt) | 1999-12-14 |
CN1192748A (zh) | 1998-09-09 |
NZ310804A (en) | 1998-10-28 |
AU6166796A (en) | 1996-12-30 |
IL122417A0 (en) | 1998-06-15 |
JP4050314B2 (ja) | 2008-02-20 |
HUP9901069A2 (hu) | 1999-07-28 |
ES2210374T3 (es) | 2004-07-01 |
KR19990022656A (ko) | 1999-03-25 |
PL323858A1 (en) | 1998-04-27 |
EP0886648A1 (en) | 1998-12-30 |
CZ391097A3 (cs) | 1998-07-15 |
EP0886648B8 (en) | 2004-03-03 |
CA2223833C (en) | 2010-12-21 |
EP1510524A3 (en) | 2006-06-07 |
TR199701557T2 (xx) | 2002-06-21 |
DE69630708D1 (de) | 2003-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO975729L (no) | Forbindelser og peptider som binder til etytropoietinreseptoren | |
NO961115D0 (no) | Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser | |
DK0765394T3 (da) | Oprensede Myceliopthora-laccaser og nukleinsyrer der koder for disse | |
FI954805A0 (fi) | Menetelmiä insuliininkaltaisen kasvutekijän sitojaproteiinien käyttämiseksi | |
DE59409672D1 (de) | Festphasensynthese von Oligoribonucleotiden | |
NO910982L (no) | Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller. | |
BR9912455A (pt) | ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória | |
NO950477D0 (no) | Aminosyrederivater | |
DE68925275T2 (de) | Endotoxin-bindeprotein und dessen verwendung | |
AU4375493A (en) | Isolated protein receptors, antibodies which bind thereto, nucleic acid sequence coding therefor, and uses thereof | |
SE9602822D0 (sv) | New receptor | |
DE69929454D1 (de) | Neue aminosäuresequenzen, deren kodierende dns, antikörper dagegen und deren verwendungen | |
DK0923644T3 (da) | G-koblet receptor, der udviser selektiv selektivitet for ATP | |
CA2199403A1 (en) | Novel PKA-Binding Proteins and Uses Thereof | |
DE69315730T2 (de) | Verfahren zur Herstellung von Peptiden und neue Zwischenverbindungen dazu | |
NO974713L (no) | Gener som koder for lymfocyttinterferon-regulatorisk faktor (LSIRF) polypeptider | |
CA2199843A1 (en) | Novel PKA-Binding Proteins and Uses Thereof | |
DK0938555T3 (da) | Konstruktioner og komplekser af cyclin E | |
WO1990003394A3 (fr) | Nouvelles lymphokines, sequences d'adn codant pour ces lymphokines et compositions pharmaceutiques contenant ces lymphokines | |
FR2710241B3 (fr) | Composition énergétique à base d'acides aminés glycogéniques. | |
EP0716146A3 (en) | A novel stem cell marker protein, antibodies thereto, compositions thereof and nucleotide sequences encoding said protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |